
Nordson (NDSN) Stock Forecast & Price Target
Nordson (NDSN) Analyst Ratings
Bulls say
Nordson's financial performance reflects a robust outlook, with the company generating approximately $2.8 billion in revenue for fiscal year 2025, demonstrating resilience across its diverse segments. Notably, the Advanced Technology Solutions segment experienced an impressive organic sales increase of 21%, driven by heightened demand for semiconductor-related products, while overall core sales growth in the Medical and Fluid Solutions and Industrial Precision Solutions segments remained steady. The company's guidance for fiscal year 2026 has been revised upward, anticipating sales in the range of $2.86 billion to $2.98 billion, representing a year-over-year growth of 2% to 7%, further underlining its strong market positioning and performance potential.
Bears say
Nordson's financial performance for fiscal 2025 shows concerning trends, with an adjusted operating profit of $166 million falling $5 million short of estimates, resulting in a $0.07 earnings per share miss despite total EPS being in line. The revenue from the Medical & Fluid Solutions segment declined 0.2%, and the adverse impacts of divestitures and an unfavorable geographic product mix contributed to a decline in EBITDA margins, which decreased by 380 basis points year-over-year. Additionally, the company continues to face challenges with unfavorable currency fluctuations historically creating earnings headwinds, further complicating its financial outlook.
This aggregate rating is based on analysts' research of Nordson and is not a guaranteed prediction by Public.com or investment advice.
Nordson (NDSN) Analyst Forecast & Price Prediction
Start investing in Nordson (NDSN)
Order type
Buy in
Order amount
Est. shares
0 shares